Entrada Therapeutics (TRDA) Stock Chart & Stock Price History $21.59 +1.27 (+6.25%) (As of 12/6/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Entrada Therapeutics Stock Price Performance 5 Day Performance+6.25%1 Month Performance+12.27%3 Month Performance+45.88%6 Month Performance+37.17%Year-To-Date Performance+43.07%1 Year Performance+61.60% Receive TRDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Is Mocking Elon, But Wait Until They See This Demo (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. TRDA Stock Chart for Saturday, December, 7, 2024 TRDA Chart by TradingView Entrada Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/06/2024$20.32$21.59+6.25%$21.63$20.4881,236 shs$807.90 million12/05/2024$19.96$20.32+1.80%$20.46$19.58119,826 shs$760.37 million12/04/2024$20.17$19.96-1.04%$20.26$19.60141,511 shs$746.90 million12/03/2024$20.32$20.17-0.74%$20.36$19.98161,090 shs$754.76 million12/02/2024$19.89$20.32+2.16%$20.50$19.65170,715 shs$760.37 million11/29/2024$19.83$19.89+0.30%$20.02$19.5278,388 shs$744.28 million Get the Latest News and Ratings for TRDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/28/2024$19.83$19.83$19.93$19.30124,306 shs$742.04 million11/27/2024$19.37$19.83+2.37%$19.93$19.30124,306 shs$742.04 million11/26/2024$19.04$19.37+1.73%$19.54$18.8196,461 shs$724.83 million11/25/2024$18.80$19.04+1.28%$19.71$18.94119,646 shs$712.48 million11/22/2024$18.05$18.80+4.16%$18.95$17.9095,863 shs$703.50 million11/21/2024$17.93$18.05+0.67%$18.40$17.6085,001 shs$675.43 million11/20/2024$17.77$17.93+0.90%$17.94$17.5268,794 shs$670.94 million11/19/2024$17.45$17.77+1.83%$17.83$17.0975,358 shs$664.95 million11/18/2024$17.85$17.45-2.24%$18.18$17.40113,145 shs$652.98 million11/15/2024$19.04$17.85-6.25%$19.23$17.71140,733 shs$667.95 million11/14/2024$19.96$19.04-4.61%$20.25$18.95157,026 shs$712.48 million11/13/2024$19.79$19.96+0.86%$20.49$19.64219,660 shs$746.90 million11/12/2024$19.89$19.79-0.50%$19.88$19.28162,819 shs$740.54 million11/11/2024$19.82$19.89+0.35%$20.21$19.58190,210 shs$744.28 million11/08/2024$19.23$19.82+3.07%$19.95$18.92239,326 shs$741.66 million11/07/2024$18.66$19.23+3.05%$19.85$18.64276,281 shs$715.36 million11/06/2024$18.62$18.66+0.21%$19.78$18.15247,621 shs$694.15 million Related Companies Twist Bioscience Stock Price Chart Vericel Stock Price Chart Bausch Health Companies Stock Price Chart MorphoSys Stock Price Chart Iovance Biotherapeutics Stock Price Chart Gemini Therapeutics Stock Price Chart ACADIA Pharmaceuticals Stock Price Chart Amneal Pharmaceuticals Stock Price Chart Catalyst Pharmaceuticals Stock Price Chart Protagonist Therapeutics Stock Price Chart Receive TRDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRDA) was last updated on 12/7/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entrada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entrada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRDA Stock Alerts